The content here is for informational purposes only, should not be taken as legal business,

tax, or investment advice, or be used to evaluate any investment or security and is not

directed at any investors or potential investors in any A16Z fund. For more details,

please see A16Z.com slash disclosures.

Hi, and welcome to the A16Z podcast. I'm Hannah and today's episode is about a

pretty universal topic, which is the idea of longevity. And by that, we mean everything from

increasing the amount of time that we're healthy to increasing our lifespan and even combating aging.

We cover everything from the latest research to tools for what we can do in our own personal lives.

This episode is based on a conversation at our summit event in November 2017 and includes Jeff Kated, CEO and co-founder of QBio, who's the first voice you'll hear after mine.

Mike Snyder, professor and chair of the Department of Genetics at Stanford, the second voice.

David Sinclair, co-director of the Glenn Center for Biology of Genetics at Stanford, the second voice, David

Sinclair, co-director of the Glenn Center for Biology of Aging at Harvard Medical School,

and Kristen Fortney, CEO and co-founder of BioAge.

This is a question I'd actually like to ask all of you, which is why now? Why is this the

moment in which we can either find disease before it occurs or actually extend

our lives? What is it that's setting the stage for this? I think it has to do with the explosion

and technology we have to measure biology because in almost any area of scientific discipline, the first

step is kind of turning it into more or less an information science. And once we have enough

information and we can start to model these complex processes, which are traditionally thought to more or less an information science. And once we have enough information,

and we can start to model these complex processes,

which are traditionally thought of as being too complex for us to understand,

but with the tremendous gains in computing power we have,

...